Financials
- Market Capitalization 2.06 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
7.71
ratio cours/chiffre d'affaires
7.82
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1961 | ADMA ADMA Biologics Inc - Common Stock | 8.97 USD | -1.21% | -3.34% | +8.60% | -51.93% | 2.08 B USD | ||
| 1963 | MESO Mesoblast Limited - American Depositary Shares | 16.22 USD | +5.05% | +12.64% | +16.77% | +44.95% | 2.08 B USD | ||
| 1966 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 35.54 USD | -3.53% | -5.07% | +3.95% | +15.02% | 2.06 B USD | ||
| 1977 | ANAB AnaptysBio, Inc. - Common Stock | 69.81 USD | +5.15% | +12.18% | +23.25% | +98.32% | 2.03 B USD |